Videos

Mark D. Duncan, MD, from The Johns Hopkins University School of Medicine, discusses demonstrable metrics that help measure the success of a patient navigation program.

Mary Lou Woodford, from the Cancer Resource Foundation, provides guidance on staying compliant with the new patient navigation accreditation standards from the American College of Surgeons Commission on Cancer.

Michael L. Krychman, MD, Executive Director of the Southern California Center for Sexual Health and Survivorship Medicine, discusses managing and treating sexual health concerns in cancer patients and survivors.

Karen Masino, from Ingalls Memorial Hospital, discusses the intricacies of developing a survivorship program.

Rajni Kannan discusses the importance patient education or managing the side effects associated ipilimumab and vemurafenib in metastatic melanoma.

Mary Gullatte, president of the Oncology Nursing Society, explains the impact that oncology nurses have on the lives of both patients and their families.

Carrie Stricker from the Abramson Cancer Center of the University of Pennsylvania on the Efficacy of Survivorship Care Plans for Posttreatment Breast Cancer Survivors.

Donna Berry, from the Dana-Farber Cancer Institute, Explains a Nurse-Led Education Program That Enhanced Oral Therapy Compliance.

Robin McConnell, from John Theurer Cancer Center, Discusses Nutrition in Cancer Care

Donna L. Berry, from Dana-Farber Cancer Institute, on Symptom Distress and Oral Therapy Adherence.

Heidi Donovan from the University of Pittsburgh School of Nursing Discusses Prioritizing Symptoms

Donna Berry, from Dana-Farber Cancer Institute, on Compliance to Oral Cancer Therapies.

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative head and neck cancers.

Kathleen Madden, from NYU Langone Medical Center, on the Importance Educating Patients About Ipilimumab's Side Effects.

Mary Gullatte, President, Oncology Nursing Society, Discusses Cancer Genetic Counseling.

Krista Rubin, from Massachusetts General Hospital Cancer Center, on Understanding Ipilimumab's Toxicities.

Dr. Linda Vahdat, from New York-Presbyterian Hospital, Discusses the Side Effects of Halaven

Dr. Linda Vahdat, from the New York-Presbyterian Hospital, Compares Halaven and Ixempra Neuropathy

Dr. Andrew Zelenetz, from Memorial Sloan-Kettering Cancer Center, Discusses the Chemotherapy Delivery Process

Dr. Wayne Bardwell from UCSD Cancer Center Expresses the Importance of Listening

Dr. Ken Fleisher from New York University Discusses Monitoring Patients With ONJ

Dr. Beth DuPree from Holy Redeemer Health System Provides Z11 Trial Takeaway Points

Dr. Kenneth Fleisher from NYU College of Dentistry Explains How Nurses Can Identify osteonecrosis of the jaw.

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University, Discusses Oncofertility Insurance Coverage

Dr. Beth DuPree from Holy Redeemer Health System Updates Nurses on Breast Cancer Treatment

Dr. Wayne Bardwell from UCSD Cancer Center on Cancer-Related Variables and Depression

Dr. Teresa Woodruff from the Oncofertility Consortium on the Patient Navigator's Role in Oncofertility

Dr. Harold P. Freeman from Ralph Lauren Center for Cancer Care and Prevention Describes Patient Navigation